Stimulation of de Novo Pyrimidine Synthesis by Growth Signaling Through mTOR and S6K1
Author(s) -
Issam BenSahra,
Jessica J. Howell,
John M. Asara,
Brendan D. Manning
Publication year - 2013
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.1228792
Subject(s) - mtorc1 , p70 s6 kinase 1 , pi3k/akt/mtor pathway , cell growth , pyrimidine metabolism , biology , biochemistry , metabolism , microbiology and biotechnology , mechanistic target of rapamycin , enzyme , stimulation , de novo synthesis , kinase , signal transduction , chemistry , neuroscience , purine
Cellular growth signals stimulate anabolic processes. The mechanistic target of rapamycin complex 1 (mTORC1) is a protein kinase that senses growth signals to regulate anabolic growth and proliferation. Activation of mTORC1 led to the acute stimulation of metabolic flux through the de novo pyrimidine synthesis pathway. mTORC1 signaling posttranslationally regulated this metabolic pathway via its downstream target ribosomal protein S6 kinase 1 (S6K1), which directly phosphorylates S1859 on CAD (carbamoyl-phosphate synthetase 2, aspartate transcarbamoylase, dihydroorotase), the enzyme that catalyzes the first three steps of de novo pyrimidine synthesis. Growth signaling through mTORC1 thus stimulates the production of new nucleotides to accommodate an increase in RNA and DNA synthesis needed for ribosome biogenesis and anabolic growth.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom